Literature DB >> 7039666

Dose response of oral timolol combined with adrenaline.

A Ohrström.   

Abstract

Oral timolol, a beta-adrenergic receptor blocker, was given in 5 different doses from 5 mg to 30 mg a day to 12 healthy volunteers in a double-blind cross-over trial. Adrenaline was instilled into one eye in each subject. Recording of intraocular pressure during the trial suggested the presence of a dose-response relationship between the dose of timolol and the decrease of intraocular pressure. An analysis of the interaction of timolol and adrenaline showed that the adrenaline effect diminished linearly with increasing timolol dose, which finally made the combination less effective than timolol alone.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7039666      PMCID: PMC1039765          DOI: 10.1136/bjo.66.4.242

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  [Effects of oral bupranolol on aqueous dynamics in primary open-angle glaucoma (a preliminary report) (author's transl)].

Authors:  M Takase; H Nanba
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1976-07-10

Review 2.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

3.  Treatment of ocular hypertension with oral beta-adrenergic blocking agents.

Authors:  M Pandolfi; A Ohrström
Journal:  Acta Ophthalmol (Copenh)       Date:  1974

4.  Clinical experience with propranolol in the treatment of glaucoma.

Authors:  A Ohrström
Journal:  Acta Ophthalmol (Copenh)       Date:  1973

5.  A fluorophotometric study of the effect of topical timolol on aqueous humor dynamics.

Authors:  M E Yablonski; T J Zimmerman; S R Waltman; B Becker
Journal:  Exp Eye Res       Date:  1978-08       Impact factor: 3.467

6.  Timolol. A beta-adrenergic blocking agent for the treatment of glaucoma.

Authors:  T J Zimmerman; H E Kaufman
Journal:  Arch Ophthalmol       Date:  1977-04

7.  Long-term experience with timolol ophthalmic solution in patients with open-angle glaucoma.

Authors:  W P Boger; C A Puliafito; R F Steinert; D P Langston
Journal:  Ophthalmology       Date:  1978-03       Impact factor: 12.079

8.  Atenolol versus adrenaline eye drops and an evaluation of these two combined.

Authors:  C I Phillips; S M Gore; P M Gunn
Journal:  Br J Ophthalmol       Date:  1978-05       Impact factor: 4.638

9.  The treatment of glaucoma with propranolol (Inderal). A clinical trial.

Authors:  A Borthne
Journal:  Acta Ophthalmol (Copenh)       Date:  1976-07

10.  Long-term treatment of glaucoma with systemic propranolol.

Authors:  A Ohrström; M Pandolfi
Journal:  Am J Ophthalmol       Date:  1978-09       Impact factor: 5.258

View more
  1 in total

Review 1.  Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects.

Authors:  A M Brooks; W E Gillies
Journal:  Drugs Aging       Date:  1992 May-Jun       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.